These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9266988)

  • 1. Mechanisms of protection induced by attenuated simian immunodeficiency virus. I. Protection cannot be transferred with immune serum.
    Almond N; Rose J; Sangster R; Silvera P; Stebbings R; Walker B; Stott EJ
    J Gen Virol; 1997 Aug; 78 ( Pt 8)():1919-22. PubMed ID: 9266988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to superinfection by a vigorously replicating, uncloned stock of simian immunodeficiency virus (SIVmac251) stimulates replication of a live attenuated virus vaccine (SIVmacC8).
    Berry N; Stebbings R; Ferguson D; Ham C; Alden J; Brown S; Jenkins A; Lines J; Duffy L; Davis L; Elsley W; Page M; Hull R; Stott J; Almond N
    J Gen Virol; 2008 Sep; 89(Pt 9):2240-2251. PubMed ID: 18753233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Passive immunization of cynomolgus macaques with immune sera or a pool of neutralizing monoclonal antibodies failed to protect against challenge with SIVmac251.
    Kent KA; Kitchin P; Mills KH; Page M; Taffs F; Corcoran T; Silvera P; Flanagan B; Powell C; Rose J
    AIDS Res Hum Retroviruses; 1994 Feb; 10(2):189-94. PubMed ID: 8198871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo resistance to simian immunodeficiency virus superinfection depends on attenuated virus dose.
    Cranage MP; Sharpe SA; Whatmore AM; Polyanskaya N; Norley S; Cook N; Leech S; Dennis MJ; Hall GA
    J Gen Virol; 1998 Aug; 79 ( Pt 8)():1935-44. PubMed ID: 9714241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Live attenuated simian immunodeficiency virus prevents super-infection by cloned SIVmac251 in cynomolgus monkeys.
    Titti F; Sernicola L; Geraci A; Panzini G; Di Fabio S; Belli R; Monardo F; Borsetti A; Maggiorella MT; Koanga-Mogtomo M; Corrias F; Zamarchi R; Amadori A; Chieco-Bianchi L; Verani P
    J Gen Virol; 1997 Oct; 78 ( Pt 10)():2529-39. PubMed ID: 9349474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8+ lymphocytes do not mediate protection against acute superinfection 20 days after vaccination with a live attenuated simian immunodeficiency virus.
    Stebbings R; Berry N; Waldmann H; Bird P; Hale G; Stott J; North D; Hull R; Hall J; Lines J; Brown S; D'Arcy N; Davis L; Elsley W; Edwards C; Ferguson D; Allen J; Almond N
    J Virol; 2005 Oct; 79(19):12264-72. PubMed ID: 16160152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of protection induced by attenuated simian immunodeficiency virus. II. Lymphocyte depletion does not abrogate protection.
    Stebbings R; Stott J; Almond N; Hull R; Lines J; Silvera P; Sangster R; Corcoran T; Rose J; Cobbold S; Gotch F; McMichael A; Walker B
    AIDS Res Hum Retroviruses; 1998 Sep; 14(13):1187-98. PubMed ID: 9737590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection from pathogenic SIVmac challenge following short-term infection with a nef-deficient attenuated virus.
    Norley S; Beer B; Binninger-Schinzel D; Cosma C; Kurth R
    Virology; 1996 May; 219(1):195-205. PubMed ID: 8623530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of protection induced by attenuated simian immunodeficiency virus. IV. Protection against challenge with virus grown in autologous simian cells.
    Almond N; Corcoran T; Hull R; Walker B; Rose J; Sangster R; Silvera K; Silvera P; Cranage M; Rud E; Stott EJ
    J Med Primatol; 1997; 26(1-2):34-43. PubMed ID: 9271187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
    Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
    Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells.
    Almond N; Kent K; Cranage M; Rud E; Clarke B; Stott EJ
    Lancet; 1995 May; 345(8961):1342-4. PubMed ID: 7752758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated exposure of rhesus macaques to low doses of simian immunodeficiency virus (SIV) did not protect them against the consequences of a high-dose SIV challenge.
    Dittmer U; Stahl-Hennig C; Coulibaly C; Nisslein T; Lüke W; Fuchs D; Bodemer W; Petry H; Hunsmann G
    J Gen Virol; 1995 Jun; 76 ( Pt 6)():1307-15. PubMed ID: 7782761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal or neonatal infection with attenuated simian immunodeficiency virus results in protective immunity against oral challenge with pathogenic SIVmac251.
    Otsyula MG; Miller CJ; Tarantal AF; Marthas ML; Greene TP; Collins JR; van Rompay KK; McChesney MB
    Virology; 1996 Aug; 222(1):275-8. PubMed ID: 8806509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with virion-derived glycoprotein 130 from HIV-2 or SIV protects macaques against challenge virus grown in human or simian cells or prepared ex vivo.
    Stahl-Hennig C; Coulibaly C; Petry H; Voss G; Dittmer U; Bodemer W; Makoschey B; Jurkiewicz E; Lüke W; Hunsmann G
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S27-32. PubMed ID: 7865316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model.
    Suh YS; Park KS; Sauermann U; Franz M; Norley S; Wilfingseder D; Stoiber H; Fagrouch Z; Heeney J; Hunsmann G; Stahl-Hennig C; Sung YC
    Vaccine; 2006 Mar; 24(11):1811-20. PubMed ID: 16274888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of live-attenuated and whole-inactivated simian immunodeficiency virus vaccines against vaginal challenge with virulent SIV.
    Marthas ML; Miller CJ; Sutjipto S; Higgins J; Torten J; Lohman BL; Unger RE; Ramos RA; Kiyono H; McGhee JR
    J Med Primatol; 1992; 21(2-3):99-107. PubMed ID: 1433273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-lasting protection by live attenuated simian immunodeficiency virus in cynomolgus monkeys: no detection of reactivation after stimulation with a recall antigen.
    Sernicola L; Corrias F; Koanga-Mogtomo ML; Baroncelli S; Di Fabio S; Maggiorella MT; Belli R; Michelini Z; Macchia I; Cesolini A; Cioè L; Verani P; Titti F
    Virology; 1999 Apr; 256(2):291-302. PubMed ID: 10191194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macaques infected with attenuated simian immunodeficiency virus resist superinfection with virulence-revertant virus.
    Sharpe SA; Whatmore AM; Hall GA; Cranage MP
    J Gen Virol; 1997 Aug; 78 ( Pt 8)():1923-7. PubMed ID: 9266989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of protective efficacy of recombinant subunit vaccines against simian immunodeficiency virus infection of macaques.
    Hu SL; Abrams K; Misher L; Stallard V; Moran P; Zarling JM; Langlois AJ; Kuller L; Morton WR; Benveniste RE
    J Med Primatol; 1992; 21(2-3):119-25. PubMed ID: 1433262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid development of vaccine protection in macaques by live-attenuated simian immunodeficiency virus.
    Stahl-Hennig C; Dittmer U; Nisslein T; Petry H; Jurkiewicz E; Fuchs D; Wachter H; Mätz-Rensing K; Kuhn EM; Kaup FJ; Rud EW; Hunsmann G
    J Gen Virol; 1996 Dec; 77 ( Pt 12)():2969-81. PubMed ID: 9000087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.